InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Azelby Robert. Director active across 3 companies, notably CARDINAL HEALTH INC. Aggregated, 9 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €19k. History available since 15 March 2024. The latest transaction was disclosed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Azelby Robert is a director at ADC Therapeutics SA, CARDINAL HEALTH INC and Tango Therapeutics, Inc. The record shows 8 filings in total, and across the 8 sampled filings between 2024-03-18 and 2026-06-23, sell volume totals EUR 18,821 and the modal transaction nature is Attribution.